Publication

Population pharmacokinetic modeling of ilaprazole in healthy subjects and patients with duodenal ulcer in China

Learn how the first Chinese PopPK model shows weight, sex, and ulcer status influence ilaprazole…

CertaraJanuary 10, 2024

Publication

Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application

Find out how triple‑drug ocular PK‑PD modelling identifies optimal dosing frequency for keratitis therapy using…

CertaraDecember 31, 2023

Press Coverage

Modeling and simulation in pediatric drug development

Published: December 21, 2023 This is the article written in German, published on pharmind. Children's…

CertaraDecember 21, 2023

Publication

Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation

Explore how validated LC‑MS/MS and PK‑PD simulation support pathogen‑specific dosing for microbial keratitis using Phoenix…

CertaraDecember 13, 2023

Publication

Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions

Discover how capsule and tablet rivaroxaban formulations are bioequivalent with comparable safety, analysed using Phoenix…

CertaraNovember 23, 2023

Publication

Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers

See how high‑fat meals increase globalagliatin exposure by 25–35%, supporting food‑related dosing guidance using Phoenix…

CertaraNovember 20, 2023

Publication

Population pharmacokinetics of rivaroxaban in Chinese deep vein thrombosis patients and the exposure simulation for dosing recommendation.

Learn how eGFR strongly influences rivaroxaban clearance; PopPK modelling supports renal‑based dose reductions using Phoenix…

CertaraNovember 11, 2023

Publication

Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms

Find out how CYP2C19 polymorphisms significantly affect esomeprazole exposure and half‑life, analysed using Phoenix WinNonlin.

CertaraSeptember 29, 2023

Conference

KIC Korea 2026

–

CertaraSeptember 22, 2023

Publication

Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia

Explore how age increases dasatinib exposure; PopPK modelling supports lower dosing in elderly Chinese CML…

CertaraSeptember 19, 2023

Clinical Pharmacology

Population pharmacokinetic modeling of ilaprazole in healthy subjects and patients with duodenal ulcer in China

Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application

Modeling and simulation in pediatric drug development

Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation

Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions

Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers

Population pharmacokinetics of rivaroxaban in Chinese deep vein thrombosis patients and the exposure simulation for dosing recommendation.

Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms

KIC Korea 2026

Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia

Newsletter sign up

Quick links

Solutions

Contact